The plasma derived medicine market includes various plasma derived products used for the treatment of disease conditions. Some key plasma derived medicines include immunoglobulins, coagulation factor concentrates, albumin, and hyperimmune globulins. Immunoglobulins are widely utilized to treat primary immunodeficiencies and neurological disorders. Likewise, coagulation factor concentrates find significant applications in hemophilia. Plasma collection and fractionation involves complex manufacturing processes to Plasma Derived Medicine Market Growth these high-value biopharmaceuticals from human plasma.

The global plasma derived medicine market is estimated to be valued at US$ 33,450 million in 2021 and expected to exhibit a CAGR of 6.8% during the forecast period (2021-2028).

Key Takeaways

Key players operating in the Plasma Derived Medicine market are Grifols, S.A., SK Plasma, Fusion Healthcare, Takeda Pharmaceutical Company Limited, LFB, Octapharma AG, CSL Limited, Bio Products Laboratory Ltd., China Biologic Products Holdings, Inc., Kedrion.

The growing prevalence of immune disorders and bleeding disorders is anticipated to drive the demand for plasma derived medicines. For instance, according to World Federation of Hemophilia, over 1,00,000 people are diagnosed with hemophilia worldwide each year.

Gets More Insights on, Plasma Derived Medicine Market